focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: Glencore Non-Executive Cuts Stake

Fri, 22nd May 2015 13:01

Director Dealings Summary - Week Ended May 22        
Company Name Position Number of Shares Resulting Holding *Note GBP Value
             
BUYS            
             
Topps Tiles Matthew Williams CEO 1 million 1.7 million   1,270,000
Countrywide Alison Platt CEO 41,700 41,700 Appointed CEO in September 2014. 248,000
Rank Group Henry Birch CEO 100,000 100,000 Same day as  Rank said it expects  full year results to meet management expectations.  205,000
Homeserve John Gibson Chairman 40,000 115,000 Day after reporting higher profit and said it would pay a special dividend of GBP97 million. 172,000
Sage Group Jonathan Howell Non-Executive Director 18,167 Undisclosed   103,000
AG Barr Stuart Lorimer CFO 14,000 1.1 million   87,000
Homeserve Ben Mingay Non-Executive Director 20,000 40,000 Day after reporting higher profit and said it would pay a special dividend of GBP97 million. 86,000
Inspired Capital Jeremy Coombes Interim CEO 535,000 2.9 million   75,000
Rank Group Clive Jennings CFO 25,000 25,000 Same day as  Rank said it expects  full year results to meet management expectations..  51,000
STM Group Michael Riddell Chairman 137,000 Undisclosed Week after STM said it made good start to 2015 and said trading so far this year is in line with its expectations. 49,000
Homeserve Stella David Non-Executive Director 10,450 28,138 2 days after reporting higher profit and said it would pay a special dividend of GBP97 million. 45,000
Mitchells & Butlers Eddie Irwin Non-Executive Director 10,000 30,000   45,000
Amara Mining John McGloin Chairman 271,249 1.6 million   41,000
McBride Chris Smith CFO 25,657 25,657 Appointed in January. 24,000
Oxford Biomedica Tim Watts CFO 194,174 5.8 million   19,000
Symphony Environmental Michael Stephen Deputy Chairman 151,000 933,998   15,000
Symphony Environmental Michael Laurier CEO 150,000 23 million   14,000
Verona Pharma David Ebsworth Chairman 300,000 3.6 million Week after Verona Pharma  posted a widened pretax loss for 2014. 11,000
Lekoil Greg Eckersley Non-Executive Director 50,000 2.8 million Week after Lekoil said its pretax loss narrowed as administrative and finance costs fell. 10,000
Oxford Biomedica Andrew Heath Non-Executive Director 100,000 1.1 million   10,000
Mortgage Advice Bureau Lucy Tilley CFO 4,500 4,500 Appointed in March. Was previously a director in Canaccord Genuity's corporate broking team, which worked on company's AIM listing. 9,900
Airea Roger Salt CFO 58,738 228,738   9,000
Symphony Environmental Ian Bristow CFO 100,000 1.2 million   9,000
K3 Business Technology Brian Davies CFO 2,253 9,537 Bought shares from CEO David Bolton 5,600
Verona Pharma Biresh Roy CFO 150,000 900,000 Week after Verona Pharma  posted a widened pretax loss for 2014. 5,000
Symphony Environmental Nirj Deva Chairman 50,000 363,925   4800
Verona Pharma Jan-Anders Karlsson CEO 135,000 2.9 million Week after Verona Pharma  posted a widened pretax loss for 2014. 4,700
Symphony Environmental Nicholas Clavel Non-Executive Director 50,000 550,000   4,500
             
SELLS            
             
Glencore William Macaulay Non-Executive Director 28 million 42 million Sold by FR Galaxy Holdings, an investment vehicle connected to Macaulay. 84,000,000
Moneysupermarket Simon Nixon Founder & non-executive deputy chairman 20 million 69.8 million The amount of shares sold is at the top end of the range. Credit Suisse, the sole bookrunner on the placing, said it would sell a stake of between 2.8% and 3.7% on behalf of Nixon, who retains a 12.8% holding. 56,000,000
Merlin Entertainments Nick Mackenzie Manager 440,000 1.5 million Same day as Merlin reported growth in revenue boosted by new site openings, features and good weather, as it continues strategic expansion plans. 2,000,000
Countrywide Grenville Turner Chairman 300,000 171,524   1,800,000
Hays Paul Venables CFO 750,000 953,014   1,200,000
Sthree Justin Hughes Corporate Executive Officer 267,500 390,867 Has sold parcels of shares in quick succession since May 12. 1,000,000
Euromoney Peter Ensor Chairman 20,421 175,918 Same day as interim ex-dividend date. 245,000
Bloomsbury Publishing Nigel Newton CEO 132,651 1.1 million Day after Bloomsbury posted a small rise in pretax profit and said trading in its current year has been good across all of its divisions. 232,000
ITV David Osborn HR Director 35,900 Nil   97,000
Rolls-Royce Jason Smith Divisional CEO 2,850 19,582   29,000
K3 Business Technology David Bolton CEO 2,253 994,961 Sold shares to CFO Brian Davies.  
             
*Note: A recent company event around the time of the dealing does not suggest the dealing took place because of that event.
When a spouse or related party to a director buys shares, the resulting holding is the beneficial holding of the director
             
Contact: +44 207 199 0340; newsroom@alliancenews.com; @AllNewsTeam      
             
Copyright 2015 Alliance News Limited. All Rights Reserved.        

More News
29 Oct 2020 19:09

IN BRIEF: Verona Pharma Says Third Quarter Loss Widens

IN BRIEF: Verona Pharma Says Third Quarter Loss Widens

Read more
22 Oct 2020 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
21 Sep 2020 14:12

IN BRIEF: Verona Pharma To Delist From AIM But Remain On Nasdaq

IN BRIEF: Verona Pharma To Delist From AIM But Remain On Nasdaq

Read more
14 Sep 2020 13:13

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

Read more
24 Aug 2020 11:09

Verona Pharma Says Study Shows Ensifentrine Improves Lung Function

Verona Pharma Says Study Shows Ensifentrine Improves Lung Function

Read more
19 Aug 2020 10:35

Verona Pharma Makes Progress In Phase Two Of Inhaler Clinical Trial

Verona Pharma Makes Progress In Phase Two Of Inhaler Clinical Trial

Read more
14 Aug 2020 12:12

LONDON MARKET MIDDAY: Travel Stocks Suffer As UK Extends Quarantine

LONDON MARKET MIDDAY: Travel Stocks Suffer As UK Extends Quarantine

Read more
14 Aug 2020 10:56

UK WINNERS & LOSERS SUMMARY: Airlines Hit As UK Quarantine List Grows

UK WINNERS & LOSERS SUMMARY: Airlines Hit As UK Quarantine List Grows

Read more
14 Aug 2020 09:22

Verona To Trial Ensifentrine For Covid-19; First Half Loss Widens

Verona To Trial Ensifentrine For Covid-19; First Half Loss Widens

Read more
14 Aug 2020 07:45

LONDON MARKET PRE-OPEN: easyJet Raises Cash From Aircraft Sale

LONDON MARKET PRE-OPEN: easyJet Raises Cash From Aircraft Sale

Read more
17 Jul 2020 10:49

UK WINNERS & LOSERS SUMMARY: Verona Pharma Rises After Huge Fundraise

UK WINNERS & LOSERS SUMMARY: Verona Pharma Rises After Huge Fundraise

Read more
17 Jul 2020 08:29

Verona Pharma Shares Surge As It Raises USD200 Million For Drug Trial

Verona Pharma Shares Surge As It Raises USD200 Million For Drug Trial

Read more
9 Apr 2020 16:09

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
14 Feb 2020 10:41

UK WINNERS & LOSERS SUMMARY: RBS Plummets As Dividend Lags Consensus

UK WINNERS & LOSERS SUMMARY: RBS Plummets As Dividend Lags Consensus

Read more
3 Feb 2020 14:42

Verona Pharma Changes Top Management With New CEO, Finance Head

Verona Pharma Changes Top Management With New CEO, Finance Head

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.